Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported... Oncol Ther (2018) 6:189–201 https://doi.org/10.1007/s40487-018-0065-7 ORIGINAL RESEARCH Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) . . . . . Tian Qi Wang Joseph N. Samuel M. Catherine Brown Ashlee Vennettilli Hannah Solomon . . . . . . Lawson Eng Mindy Liang Gursharan Gill Zahra Merali Chenchen Tian Nicholas Y. H. Cheng . . . . Matthew Campbell Devalben Patel Ai Xin Liu Geoffrey Liu Doris Howell Received: May 9, 2018 / Published online: October 22, 2018 The Author(s) 2018 chemotherapy, captured chemotoxicities and ABSTRACT respective severities. Patient telephone surveys assessed whether healthcare providers had Introduction: Systematic documentation of addressed chemotoxicities to the patients’ chemotoxicities in outpatient clinics is chal- satisfaction. lenging. Incorporating patient-reported out- Results: Over a broad demographic of 497 come (PRO) measures in clinical workflows can patients receiving chemotherapy, 90% (95% CI be an efficient strategy to strengthen the 84–96%) with significant chemotoxicities assessment of symptomatic treatment toxicities (n = 107) reported that their providers had dis- in oncology clinical practice. We compared the cussed toxicities with them; of these, 70% adequateness, feasibility, and acceptability of received a therapy management change, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Download PDF
13 pages

Loading next page...
 
/lp/springer-journals/routine-surveillance-of-chemotherapy-toxicities-in-cancer-patients-WlVacikpgU
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-018-0065-7
Publisher site
See Article on Publisher Site

Abstract

Oncol Ther (2018) 6:189–201 https://doi.org/10.1007/s40487-018-0065-7 ORIGINAL RESEARCH Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) . . . . . Tian Qi Wang Joseph N. Samuel M. Catherine Brown Ashlee Vennettilli Hannah Solomon . . . . . . Lawson Eng Mindy Liang Gursharan Gill Zahra Merali Chenchen Tian Nicholas Y. H. Cheng . . . . Matthew Campbell Devalben Patel Ai Xin Liu Geoffrey Liu Doris Howell Received: May 9, 2018 / Published online: October 22, 2018 The Author(s) 2018 chemotherapy, captured chemotoxicities and ABSTRACT respective severities. Patient telephone surveys assessed whether healthcare providers had Introduction: Systematic documentation of addressed chemotoxicities to the patients’ chemotoxicities in outpatient clinics is chal- satisfaction. lenging. Incorporating patient-reported out- Results: Over a broad demographic of 497 come (PRO) measures in clinical workflows can patients receiving chemotherapy, 90% (95% CI be an efficient strategy to strengthen the 84–96%) with significant chemotoxicities assessment of symptomatic treatment toxicities (n = 107) reported that their providers had dis- in oncology clinical practice. We compared the cussed toxicities with them; of these, 70% adequateness, feasibility, and acceptability of received a therapy management change,

Journal

Oncology and Therapy – Springer Journals

Published: Oct 22, 2018

References

  • 2015: a report by the American Society of Clinical Oncology
  • Pharmacovigilance in oncology: evaluation of current practice and future perspectives
    Baldo, P; Paoli, P
  • Comparison between patient-reported and clinician-observed symptoms in oncology
    Xiao, C; Polomano, R; Bruner, DW
  • Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
    Maio, M; Gallo, C; Leighl, NB
  • Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.
    Henry, DH; Viswanathan, HN; Elkin, EP
  • A systematic review of utility values for chemotherapy-related adverse events
    Shabaruddin, FH; Chen, LC; Elliott, RA
  • Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients
    Kangas, M; Bovbjerg, DH; Montgomery, GH
  • Improving quality of care by obtaining patient-reported outcomes (PRO)-CTCAE chemotoxicities using tablet technology in daycare (DC) waiting rooms
    Wang, TQ; Brown, C; Vennettilli, A
  • Oral mucositis induced by anticancer treatments: physiopathology and treatments
    Lionel, D; Christophe, L; Marc, A; Jean-Luc, C
  • The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study
    Cleeland, CS; Zhao, F; Chang, VT
  • Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients
    Kayl, AE; Meyers, CA
  • Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers: results of a prospective study
    Hackbarth, M; Haas, N; Fotopoulou, C
  • The impact of chemotherapy-induced nausea and vomiting on health-related quality of life
    Ballatori, E; Roila, F; Ruggeri, B
  • Chemotherapy-induced nausea and vomiting incidence and impact on patient quality of life at community oncology settings
    Cohen, L; Moor, C; Eisenberg, P
  • How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30
    Fromme, EK; Eilers, KM; Mori, M
  • Health care providers underestimate symptom intensities of cancer patients: a multicenter European study
    Laugsand, EA; Sprangers, MA; Bjordal, K
  • Reliability of adverse symptom event reporting by clinicians
    Atkinson, TM; Li, Y; Coffey, CW
  • Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events
    Basch, E; Bennett, A; Pietanza, mc
  • Assessing health-related quality of life in palliative care: comparing patient and physician assessments
    Petersen, MA; Larsen, H; Pedersen, L
  • A review of the reliability and validity of the Edmonton symptom assessment system
    Richardson, LA; Jones, GW
  • Quality of life: questionnaires and questions
    Mooney, A
  • What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials
    Kotronoulas, G; Kearney, N; Maguire, R
  • Do patients and physicians agree in their assessment of the severity of psoriasis? Insights from tofacitinib phase 3 clinical trials
    Carle, P; Andrew, G; Bushmakin, J
  • Lack of congruence in the ratings of patients’ health status by patients and their physicians
    Suarez-Almazor, ME; Conner-Spady, B; Kendall, CJ
  • A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting
    Chen, J; Ou, L; Hollis, SJ
  • Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial
    Velikova, G; Booth, L; Smith, AB
  • Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors
    Howell, D; Molloy, S; Wilkinson, K
  • Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers’ use of the information: a randomized controlled clinical trial
    Mooney, KH; Beck, SL; Friedman, RH
  • Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication
    Takeuchi, EE; Keding, A; Awad, N
  • Patient-reported outcome measures for follow-up after gynaecological cancer treatment
    Nama, V; Nordin, A; Bryant, A
  • American Society of Clinical Oncology policy statement on clinical pathways in oncology
    Zon, RT; Frame, JN; Neuss, MN
  • EQ-5D: a measure of health status from the EuroQol Group
    Rabin, R; Charro, F
  • Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample
    Sullivan, PW; Ghushchyan, V
  • Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden
    Giesinger, JM; Wintner, LM; Zabernigg, A
  • Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter?
    Coolbrandt, A; Heede, KV; Vanhove, E
  • Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial
    Basch, E; Deal, AM; Kris, MG
  • Chart reviews in emergency medicine research: where are the methods?
    Gilbert, EH; Lowenstein, SR; Koziol-McLain, J
  • The retrospective chart review: important methodological considerations
    Vassar, M; Holzmann, M
  • Chemotherapeutic medications and their emergent complications
    Young, JS; Simmons, JW
  • does chemotherapy really affect the quality of life of women with breast cancer?
    Hwang, SY; Chang, SJ; Park, B-W
  • The impact of outpatient chemotherapy-related adverse events on the quality of life of breast cancer patients
    Tachi, T; Teramachi, H; Tanaka, K
  • Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy
    Ballatori, E; Roila, F